Tarek A. Bin Yameen1, Vaibhav Gupta1, Abdollah Behzadi1. 1. From the Faculty of Medicine, University of Toronto, Toronto, Ont. (Bin Yameen, Gupta, Behzadi); the Division of Thoracic Surgery, Department of Surgery, Trillium Health Partners, University of Toronto, Toronto, Ont. (Gupta, Behzadi); and the Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ont. (Gupta).
Abstract
Background: Observational studies comparing uniportal and multiportal video-assisted thoracoscopic surgery (VATS) in the treatment of lung cancer have produced conflicting results. We present a Canadian study comparing clinical outcomes of uniportal and multiportal VATS in the treatment of lung cancer. Methods: A retrospective study evaluating patients who underwent multiportal (2012–2014) or uniportal (2014–2016) VATS lobectomies, segmentectomies and wedge resections for lung cancer. Clinical outcomes measured included patient demographics, tumour factors, operative factors, length of hospital stay, postoperative complications, analgesic use, pain scores and mortality. Descriptive statistics were used to compare the 2 groups. Results: Of 185 patients, 65 underwent uniportal and 63 underwent multiportal VATS resection. Patients were similar in terms of their baseline demographics, comorbidies and cancer characteristics. Median operative time was 184 and 185 minutes in the uniportal and multiportal groups, respectively. There were 5 conversions to thoracotomy in the uniportal group and 1 in the multiportal group. Similar lymph node retrieval (median 7 v. 5 nodes) and positive margin rates (6.2% v. 4.8%) were seen in the 2 groups. Median length of stay was 2 days (interquartile range [IQR] 1–3) and 3 days (IQR 2–4) in the uniportal and multiportal groups, respectively. Rates of postoperative complications were similar in the 2 groups (16.9% v. 19.0%, p = 0.76). Patient-controlled analgesia use and pain scores did not differ between the groups. Conclusion: Adoption of uniportal VATS appears to be feasible and safe, without compromising oncologic principles or increasing intraoperative resource utilization. Larger, prospective studies can help confirm these findings.
Background: Observational studies comparing uniportal and multiportal video-assisted thoracoscopic surgery (VATS) in the treatment of lung cancer have produced conflicting results. We present a Canadian study comparing clinical outcomes of uniportal and multiportal VATS in the treatment of lung cancer. Methods: A retrospective study evaluating patients who underwent multiportal (2012–2014) or uniportal (2014–2016) VATS lobectomies, segmentectomies and wedge resections for lung cancer. Clinical outcomes measured included patient demographics, tumour factors, operative factors, length of hospital stay, postoperative complications, analgesic use, pain scores and mortality. Descriptive statistics were used to compare the 2 groups. Results: Of 185 patients, 65 underwent uniportal and 63 underwent multiportal VATS resection. Patients were similar in terms of their baseline demographics, comorbidies and cancer characteristics. Median operative time was 184 and 185 minutes in the uniportal and multiportal groups, respectively. There were 5 conversions to thoracotomy in the uniportal group and 1 in the multiportal group. Similar lymph node retrieval (median 7 v. 5 nodes) and positive margin rates (6.2% v. 4.8%) were seen in the 2 groups. Median length of stay was 2 days (interquartile range [IQR] 1–3) and 3 days (IQR 2–4) in the uniportal and multiportal groups, respectively. Rates of postoperative complications were similar in the 2 groups (16.9% v. 19.0%, p = 0.76). Patient-controlled analgesia use and pain scores did not differ between the groups. Conclusion: Adoption of uniportal VATS appears to be feasible and safe, without compromising oncologic principles or increasing intraoperative resource utilization. Larger, prospective studies can help confirm these findings.
Authors: Diego Gonzalez-Rivas; Marina Paradela; Ricardo Fernandez; Maria Delgado; Eva Fieira; Lucía Mendez; Carlos Velasco; Mercedes de la Torre Journal: Ann Thorac Surg Date: 2012-12-05 Impact factor: 4.330
Authors: Christopher W Seder; Cameron D Wright; Andrew C Chang; Jane M Han; Donna McDonald; Benjamin D Kozower Journal: Ann Thorac Surg Date: 2016-03-31 Impact factor: 4.330
Authors: Christopher G Harris; Rebecca S James; David H Tian; Tristan D Yan; Mathew P Doyle; Diego Gonzalez-Rivas; Christopher Cao Journal: Ann Cardiothorac Surg Date: 2016-03
Authors: Jae Ho Chung; Yong Soo Choi; Jong Ho Cho; Hong Kwan Kim; Jhingook Kim; Jae Ill Zo; Young Mog Shim Journal: Interact Cardiovasc Thorac Surg Date: 2015-03-03